Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06076863 · ClinicalTrials.gov registry record · NA
Pharmacist Management of Paxlovid eVisits
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 2,478
- Enrollment target
NCT06076863 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 2,478 participants.
The verdict
NCT06076863, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,478 participants
- Enrollment target
Study Summary
The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for common potential drug-drug interactions and time to prescription, as well as the time and financial costs of care in the two groups.
Interventions
- OTHER Pharmacist Care
- OTHER AFM Pool Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,478 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2024-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06076863
The ClinicalTrials.gov registry entry for NCT06076863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,478 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharmacist Care is the first listed.
NCT06076863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06076863 about?
NCT06076863 is a clinical study titled "Pharmacist Management of Paxlovid eVisits". The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for com...
What is the current status of trial NCT06076863?
This trial is currently completed. It is a NA study. The enrollment target is 2,478 participants. The study started on 2023-10-09. Estimated completion is 2024-01-11.
What interventions are being tested in trial NCT06076863?
The interventions under investigation include: Pharmacist Care (OTHER), AFM Pool Care (OTHER).
Who is sponsoring clinical trial NCT06076863?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.